Literature DB >> 15923286

Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis.

G S Ogilvie1, D M Patrick, M Schulzer, J W Sellors, M Petric, K Chambers, R White, J M FitzGerald.   

Abstract

BACKGROUND/
OBJECTIVES: Providing summary recommendations regarding self collection of vaginal specimens for human papillomavirus (HPV) testing is difficult owing to the wide range of published estimates for the diagnostic accuracy of this approach. To determine summary estimates from analyses of reported findings of the sensitivity, specificity and summary receiver operating characteristic curves (SROC) for self collected vaginal specimens for HPV testing compared to the reference standard, clinician collected HPV specimens.
METHODS: Standard search criteria for a diagnostic systematic review were employed. Eligible studies were combined using a random effects model and summary ROC curves were derived for overall and for specific subgroups.
RESULTS: Summary measures were determined from 12 studies. Six studies where patients used Dacron or cotton swabs or cytobrushes to obtain samples were pooled and had an overall sensitivity of 0.74 (95% CI 0.61 to 0.84) and specificity of 0.88 (95% CI 0.83 to 0.92), with diagnostic odds ratio of 22.3 and an area under the curve of 0.91. Self specimens using Dacron or cotton swabs or cytobrushes collected by women enrolled at referral clinics had an overall sensitivity of 0.81 (95% CI 0.65 to 0.91) and specificity of 0.90 (95% CI 0.80 to 0.95). Sensitivity and specificity of tampons ranged from 0.67-0.94 and 0.80-0.85 respectively.
CONCLUSIONS: Our findings indicate that the combined sensitivity for HPV-DNA is more than 70% when patients use Dacron swabs, cotton swabs, or cytobrushes to obtain their own vaginal specimens for HPV-DNA evaluation. Self collected HPV-DNA swabs may be an appropriate alternative for low resource settings or in patients reluctant to undergo pelvic examinations.

Entities:  

Mesh:

Year:  2005        PMID: 15923286      PMCID: PMC1744976          DOI: 10.1136/sti.2004.011858

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  36 in total

1.  Facilitators and barriers to cervical cancer screening among Chinese Canadian women.

Authors:  T G Hislop; M Deschamps; C Teh; C Jackson; S P Tu; Y Yasui; S M Schwartz; A Kuniyuki; V Taylor
Journal:  Can J Public Health       Date:  2003 Jan-Feb

2.  Meta-analyses of studies of the diagnostic accuracy of laboratory tests: a review of the concepts and methods.

Authors:  E C Vamvakas
Journal:  Arch Pathol Lab Med       Date:  1998-08       Impact factor: 5.534

3.  Review of the screening history of Alberta women with invasive cervical cancer.

Authors:  G C Stuart; S E McGregor; M A Duggan; J G Nation
Journal:  CMAJ       Date:  1997-09-01       Impact factor: 8.262

4.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

5.  Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations.

Authors:  L E Moses; D Shapiro; B Littenberg
Journal:  Stat Med       Date:  1993-07-30       Impact factor: 2.373

6.  Meta-analysis of Pap test accuracy.

Authors:  M T Fahey; L Irwig; P Macaskill
Journal:  Am J Epidemiol       Date:  1995-04-01       Impact factor: 4.897

7.  Comparison between vaginal tampon and cervicovaginal lavage specimen collection for detection of human papillomavirus DNA by the polymerase chain reaction. The Canadian Women's HIV Study Group.

Authors:  F Coutlée; C Hankins; N Lapointe
Journal:  J Med Virol       Date:  1997-01       Impact factor: 2.327

8.  Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia.

Authors:  J Belinson; Y L Qiao; R Pretorius; W H Zhang; P Elson; L Li; Q J Pan; C Fischer; A Lorincz; D Zahniser
Journal:  Gynecol Oncol       Date:  2001-11       Impact factor: 5.482

9.  A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.

Authors:  L A Koutsky; K K Holmes; C W Critchlow; C E Stevens; J Paavonen; A M Beckmann; T A DeRouen; D A Galloway; D Vernon; N B Kiviat
Journal:  N Engl J Med       Date:  1992-10-29       Impact factor: 91.245

10.  Tampons: a novel patient-administered method for the assessment of genital human papillomavirus infection.

Authors:  C K Fairley; S Chen; S N Tabrizi; M A Quinn; J J McNeil; S M Garland
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

View more
  54 in total

1.  Suitability of self-collected vaginal samples for cervical cancer screening in periurban villages in Andhra Pradesh, India.

Authors:  A Pavani Sowjanya; Proma Paul; Haripriya Vedantham; Gayatri Ramakrishna; D Vidyadhari; K Vijayaraghavan; Shantha Laksmi; Mrudula Sudula; Brigitte M Ronnett; Manik Das; Keerti V Shah; Patti E Gravitt
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

Review 2.  Acceptability, Feasibility and Uptake of HPV Self-Sampling Among Immigrant Minority Women: a Focused Literature Review.

Authors:  Sarah Marshall; Mandana Vahabi; Aisha Lofters
Journal:  J Immigr Minor Health       Date:  2019-12

3.  The indicating FTA elute cartridge a solid sample carrier to detect high-risk HPV and high-grade cervical lesions.

Authors:  Roosmarie P de Bie; Channa E Schmeink; Judith M J E Bakkers; Peter J F Snijders; Wim G V Quint; Leon F A G Massuger; Ruud L M Bekkers; Willem J G Melchers
Journal:  J Mol Diagn       Date:  2011-04-29       Impact factor: 5.568

4.  Circumcision of HIV-infected men and transmission of human papillomavirus to female partners: analyses of data from a randomised trial in Rakai, Uganda.

Authors:  Aaron A R Tobian; Xiangrong Kong; Maria J Wawer; Godfrey Kigozi; Patti E Gravitt; David Serwadda; Kevin P Eaton; Fred Nalugoda; Thomas C Quinn; Ronald H Gray
Journal:  Lancet Infect Dis       Date:  2011-04-12       Impact factor: 25.071

5.  Human papillomavirus DNA detection in menstrual blood from patients with cervical intraepithelial neoplasia and condyloma acuminatum.

Authors:  Sze Chuen Cesar Wong; Thomas Chi Chuen Au; Sammy Chung Sum Chan; Charles Ming Lok Chan; Money Yan Yee Lam; Benny Chung Ying Zee; Wei Mei Pong; Anthony Tak Cheung Chan
Journal:  J Clin Microbiol       Date:  2010-01-20       Impact factor: 5.948

6.  Human papillomavirus infection in women in Puerto Rico: agreement between physician-collected and self-collected anogenital specimens.

Authors:  Ana Patricia Ortiz; Josefina Romaguera; Cynthia M Pérez; Yomayra Otero; Marievelisse Soto-Salgado; Keimari Méndez; Yari Valle; Maria Da Costa; Erick Suarez; Joel Palefsky; Guillermo Tortolero-Luna
Journal:  J Low Genit Tract Dis       Date:  2013-04       Impact factor: 1.925

7.  High level of agreement between clinician-collected and self-collected samples for HPV detection among South African adolescents.

Authors:  D H Adler; A Almudevar; G E Gray; B Allan; A-L Williamson
Journal:  J Pediatr Adolesc Gynecol       Date:  2012-08       Impact factor: 1.814

8.  Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women.

Authors:  D B Blossom; R H Beigi; J J Farrell; W Mackay; B Qadadri; D R Brown; S Rwambuya; C J Walker; F S Kambugu; F W Abdul-Karim; C C Whalen; R A Salata
Journal:  J Med Virol       Date:  2007-06       Impact factor: 2.327

9.  Partner Human Papillomavirus Viral Load and Incident Human Papillomavirus Detection in Heterosexual Couples.

Authors:  Mary K Grabowski; Xiangrong Kong; Ronald H Gray; David Serwadda; Godfrey Kigozi; Patti E Gravitt; Fred Nalugoda; Steven J Reynolds; Maria J Wawer; Andrew D Redd; Stephen Watya; Thomas C Quinn; Aaron A R Tobian
Journal:  J Infect Dis       Date:  2015-11-23       Impact factor: 5.226

10.  Prevalence and type distribution of human papillomavirus in 5,000 British Columbia women--implications for vaccination.

Authors:  Richard A Moore; Gina Ogilvie; Daniel Fornika; Veronika Moravan; Marc Brisson; Mahsa Amirabbasi-Beik; Anita Kollar; Thomas Burgess; Ray Hsu; Laura Towers; Jane Lo; Jasenka Matisic; Angela Brooks-Wilson
Journal:  Cancer Causes Control       Date:  2009-05-29       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.